MedPath

Vasopressin

Generic Name
Vasopressin
Brand Names
Vasostrict
Drug Type
Small Molecule
Chemical Formula
C92H130N28O24S4
CAS Number
11000-17-2
Unique Ingredient Identifier
Y87Y826H08

Overview

Vasopressin (arginine-vasopressin or antidiuretic hormone) is a nonapeptide primarily produced in the hypothalamus that exhibits diverse physiological functions related to diuresis, hemodynamic modulation, and behaviour. Vasopressin is very similar to oxytocin, differing in the third and eighth amino acids. Despite a wide variety of functions, exogenous vasopressin is primarily used to control blood pressure during systemic shock by increasing vasoconstriction and renal fluid reuptake by acting through V and V cellular receptors. The vasopressive effect of posterior pituitary gland extracts was noted in 1895, while vasopressin itself was not purified until 1951. It has been used for more than five decades for varying conditions, including variceal bleeding, diabetes insipidus, and, more recently, vasodilatory shock. It is currently marketed under the trademark VASOSTRICT® by PAR Pharmaceuticals.

Background

Vasopressin (arginine-vasopressin or antidiuretic hormone) is a nonapeptide primarily produced in the hypothalamus that exhibits diverse physiological functions related to diuresis, hemodynamic modulation, and behaviour. Vasopressin is very similar to oxytocin, differing in the third and eighth amino acids. Despite a wide variety of functions, exogenous vasopressin is primarily used to control blood pressure during systemic shock by increasing vasoconstriction and renal fluid reuptake by acting through V and V cellular receptors. The vasopressive effect of posterior pituitary gland extracts was noted in 1895, while vasopressin itself was not purified until 1951. It has been used for more than five decades for varying conditions, including variceal bleeding, diabetes insipidus, and, more recently, vasodilatory shock. It is currently marketed under the trademark VASOSTRICT® by PAR Pharmaceuticals.

Indication

1.诊断和治疗由于缺乏抗利尿激素而引起的尿崩症,也用于其他药物效果不佳的腹部肌肉松弛; 2.脑外科手术后或头颅创伤后多尿的初期治疗; 3.用于食管、胃肠道消化道疾病的急性大出血的辅助治疗。

Associated Conditions

  • Acute Circulatory Failure

Clinical Trials

View More Clinical Trials

Sign in to access the complete clinical trial database with detailed study information.

Title
Posted
Study ID
Phase
Status
Sponsor
2024/03/04
Phase 4
Not yet recruiting
2024/01/31
Not Applicable
Recruiting
King's College Hospital NHS Trust
2024/01/22
Phase 4
ENROLLING_BY_INVITATION
2023/07/24
Phase 2
Recruiting
2023/04/10
Phase 4
Recruiting
2023/02/21
Phase 1
Recruiting
2022/10/05
Phase 3
Recruiting
2022/04/07
Not Applicable
UNKNOWN
2022/01/14
Phase 4
Withdrawn
2021/05/18
Not Applicable
Completed
University of Electronic Science and Technology of China

FDA Approved Products

View More FDA Products

Sign in to access additional FDA-approved products with detailed regulatory information.

Product Name
Manufacturer
Route
Strength
Approved
NDC Code
INTRAVENOUS
20 [USP'U] in 1 mL
2024/02/14
68083-520
INTRAVENOUS
20 [USP'U] in 1 mL
2023/03/06
42023-164
PARENTERAL
20 U in 1 mL
2023/03/09
42367-570
INTRAVENOUS
20 [USP'U] in 1 mL
2023/01/01
0517-1020
HF Acquisition Co LLC, DBA HealthFirst
INTRAVENOUS
20 [USP'U] in 1 mL
2021/11/01
51662-1314
INTRAVENOUS
20 [USP'U] in 1 mL
2022/07/01
63323-930
INTRAVENOUS
20 [USP'U] in 1 mL
2023/11/16
42023-190
INTRAVENOUS
20 [USP'U] in 100 mL
2023/09/29
0338-9640
INTRAVENOUS
40 [USP'U] in 100 mL
2023/09/29
0338-9647
INTRAVENOUS
20 [USP'U] in 1 mL
2023/11/16
42023-164

EMA Approved Products

View More EMA Products

Sign in to access additional EMA-approved products with authorization details.

Medicine Name
EMA Number
Auth. Holder
Country
Drug Type
Status
Issued
Opinion
Revision

No EMA products found

No EMA products found for this drug

HSA Approved Products

View More HSA Products

Sign in to access additional HSA-approved products with regulatory information.

Product Name
Manufacturer
Dosage Form
Strength
Approved
Approval No.

No HSA products found

No HSA products found for this drug

NMPA Approved Products

View More NMPA Products

Sign in to access additional NMPA-approved products with approval information.

Product Name
Approval No.
Manufacturer
Dosage Form
Trade Name
Strength
Type
Status
Date
Import

No NMPA products found

No NMPA products found for this drug

PPB Approved Products

Product Name
Registration Code
Company
Category
Sale Type
Reg. Date

No PPB products found

No PPB products found for this drug

TGA Approved Products

View More TGA Products

Sign in to access additional TGA-approved products with licensing information.

Product Name
ARTG ID
Sponsor
Status
Reg. Date
Ingredient

No TGA products found

No TGA products found for this drug

© Copyright 2025. All Rights Reserved by MedPath